Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)

SEK 3.21

(2.56%)

Total Assets Summary of Newbury Pharmaceuticals AB (publ)

  • Newbury Pharmaceuticals AB (publ)'s latest annual total assets in 2024 was 90.87 Million SEK , up 24.62% from previous year.
  • Newbury Pharmaceuticals AB (publ)'s latest quarterly total assets in 2024 Q4 was 90.87 Million SEK , up 0.12% from previous quarter.
  • Newbury Pharmaceuticals AB (publ) reported annual total assets of 72.91 Million SEK in 2023, down -16.09% from previous year.
  • Newbury Pharmaceuticals AB (publ) reported annual total assets of 86.9 Million SEK in 2022, up 103.01% from previous year.
  • Newbury Pharmaceuticals AB (publ) reported quarterly total assets of 90.76 Million SEK for 2024 Q3, up 7.89% from previous quarter.
  • Newbury Pharmaceuticals AB (publ) reported quarterly total assets of 84.12 Million SEK for 2024 Q2, down -10.59% from previous quarter.

Annual Total Assets Chart of Newbury Pharmaceuticals AB (publ) (2024 - 2021)

Historical Annual Total Assets of Newbury Pharmaceuticals AB (publ) (2024 - 2021)

Year Total Assets Total Assets Growth
2024 90.87 Million SEK 24.62%
2023 72.91 Million SEK -16.09%
2022 86.9 Million SEK 103.01%
2021 42.8 Million SEK 0.0%

Peer Total Assets Comparison of Newbury Pharmaceuticals AB (publ)

Name Total Assets Total Assets Difference
AcuCort AB 58.5 Million SEK -55.316%
AlzeCure Pharma AB (publ) 32 Million SEK -183.963%
BioGaia AB (publ) 2.33 Billion SEK 96.105%
Enzymatica AB (publ) 125.91 Million SEK 27.829%
Enorama Pharma AB (publ) 34.38 Million SEK -164.275%
Gabather AB (publ) 2.93 Million SEK -2994.007%
Klaria Pharma Holding AB (publ.) 73.12 Million SEK -24.277%
Moberg Pharma AB (publ) 634.73 Million SEK 85.684%
Nanexa AB (publ) 132.25 Million SEK 31.292%
ODI Pharma AB 12.27 Million SEK -640.294%
Orexo AB (publ) 786.6 Million SEK 88.448%
Probi AB (publ) 1.55 Billion SEK 94.139%
Swedencare AB (publ) 9.52 Billion SEK 99.046%
Swedish Orphan Biovitrum AB (publ) 74.02 Billion SEK 99.877%
Toleranzia AB 160.42 Million SEK 43.357%
Vivesto AB 355.87 Million SEK 74.466%